Background {#Sec1}
==========

Patient satisfaction is an important indicator of quality health care \[[@CR1]\]. High patient satisfaction has been linked to better practice guideline adherence and lower inpatient mortality rates \[[@CR2]\], as well as to greater patient acceptance and adherence to prescribed medical care \[[@CR3], [@CR4]\]. Patient satisfaction as an outcome measure is particularly important for patients diagnosed with a chronic or life-threatening condition, such as cancer, who require ongoing medical care to manage the condition. Numerous studies have examined patient satisfaction in oncology settings \[[@CR5]\]. The level of patient satisfaction reported in these studies was generally high \[[@CR5], [@CR6]\]. Previous studies also examined factors associated with patient satisfaction including patient factors, such as age, gender, and type of cancer, and patient care factors, including information provision, doctor-patient relationship, and continuity of care. However, there is little consistency in reported associations between demographic factors and patient satisfaction \[[@CR5]\]. In contrast, patient care factors, particularly information provision \[[@CR5], [@CR7]\], and a patient-centered consultation style \[[@CR8]--[@CR10]\] were important predictors of patient satisfaction. Furthermore, there is evidence that patient satisfaction might be hampered by unresolved physical symptom distress \[[@CR11]\] and psychological distress \[[@CR12]\]. While cancer patients are not one homogenous group, existing evidence for satisfaction is primarily based on studies of mixed cancer types. It is, therefore, important to examine patient satisfaction across types of cancer.

There is little information on patient satisfaction among women with advanced breast cancer. Advanced breast cancer includes both metastatic disease and locally advanced disease. Treatment advances have increased life expectancy for women with metastatic breast cancer, resulting a growing numbers of affected women living with the illness \[[@CR13]\]. While treatment prolongs these women's lives, disease progression is often inevitable and ongoing treatments impose various threats including side-effects, uncertainty, and fear of death. In contrast, locally-advanced breast cancer is a potentially-curable condition, but the prognosis is generally poor with a five-year survival of less than 50% \[[@CR14]\]. Threats of cancer recurrence and aggressive cancer treatment side-effects put additional demands on affected women. Due to the nature of the disease, women with advanced breast cancer are likely to require ongoing cancer care. Hence, it is important to examine how such women assess their cancer care services. The current study aimed to examine patient satisfaction with care over the first year and its predictors in women following the diagnosis of advanced breast cancer, here, defined as metastatic breast cancer or regional disease spread. As previous studies have shown doctor-patient communication \[[@CR5], [@CR7]\] and patient-centered models of care \[[@CR8]--[@CR10]\] influenced patient satisfaction, we tested if patients' disease and treatment information-related needs at baseline influenced subsequent patient satisfaction. We also tested if greater physical symptom distress \[[@CR11]\] and psychological distress \[[@CR12]\] at baseline predicted subsequent patient satisfaction.

Methods {#Sec2}
=======

Following ethical committee approval for multi-center studies, Cantonese/Mandarin-speaking Chinese women newly diagnosed with stage III locoregional or stage IV metastatic breast cancer awaiting or receiving initial chemotherapy were recruited consecutively from six Hong Kong public oncology/breast cancer out-patient clinics between September 2008 and October 2012. Women with linguistic or intellectual difficulties were excluded from the study. At each hospital, potential patients were identified by clinical oncologists/surgeons. A trained research assistant then approached the potential patients immediately while they were awaiting their consultation. After explanations of the study, written consent was obtained from those who agreed to participate. Participants then completed a standardized baseline face-to-face questionnaire-based interview. Face-to-face follow-up assessments were then conducted at 6 weeks, 3-, 6-, and 12-months post-baseline at the oncology out-patient clinic.

Measures {#Sec3}
--------

Patient satisfaction was assessed using the Nine-item Chinese Patient Satisfaction Questionnaire (ChPSQ-9) \[[@CR15]\]. This measure was designed for assessing patient satisfaction with the specialist out-patient services provided by doctors, nurses, and other medical staff in the Chinese population \[[@CR16]\]. The ChPSQ-9 primarily assessed the interpersonal, caring aspects of health care providers. It has been validated in the local cancer population including patients with breast cancer \[[@CR15], [@CR17]\]. Each item is rated on a 5-point Likert scale from "very dissatisfied" \[[@CR1]\] to "very satisfied" \[[@CR5]\]. Total scores range from 9 to 45, with higher scores indicating greater satisfaction. The ChPSQ-9 demonstrated good internal consistency, with Cronbach's alpha ranged from 0.88 to 0.93.

The Chinese version of the Supportive Care Needs Survey Short Form (SCNS-SF 34-C) was used to assess type and magnitude of unmet needs \[[@CR18]--[@CR20]\]. The SCNS-SF 34 has been widely used and validated for use in cancer patients. This measure has good content validity and internal reliability (Cronbach's alpha 0.82 to 0.92) \[[@CR18], [@CR19]\] and measures patients' perceived need for help in five need domains: Health system and information (HSI) (11 items); Psychological (10 items); Physical and daily living (5 items); Sexuality (3 items); Patient care and support (5 items). Patients rate the intensity of each need over the past month for each item using five-point Likert scales: 1. No need: not applicable; 2. No need: satisfied; 3. Low need; 4. Moderate need; 5. High need. Scores were converted to standardized Likert summated scores ranging from 0 to 100 when calculating domain scores, with higher scores indicating greater perceived unmet need \[[@CR20]\]. In the present study, the HSI subscale was used to assess patients' disease and treatment information-related needs.

Psychological distress was measured by the 14-item Hospital Anxiety and Depression Scales (HADS) \[[@CR21]\], comprised of 2 seven-item subscales that measure symptoms of anxiety and depression. Each item is rated on a four-point scale. Total scores for each subscale range from 0 to 21, with higher scores indicating greater distress. Scores exceeding 10 on each subscale constitute case definition for psychological morbidity, scores of 8--10 indicate subclinical caseness and scores \< 8 represent non-cases. The Chinese version of the HADS has been widely used among cancer patients and has good validity \[[@CR22]\]. Both anxiety (Cronbach's α 0,86) and depression (Cronbach's α 0.82) scales demonstrate good internal consistency. The HADS is suitable for use in cancer as it omits items addressing common vegetative symptom changes, such as fatigue or weight change, arising from physical illness which otherwise would inflate apparent depression and anxiety symptom prevalence in medical populations.

Physical symptom distress was measured using the Chinese version of the Memorial Symptom Assessment Scale Short-Form (MSAS-SF) a measure of 28 physical and 4 psychological symptoms commonly experienced by cancer patients \[[@CR23], [@CR24]\]. Patients indicate if they have experienced the listed symptoms over the past week and, if so, rate the intensity of distress (five-point Likert scale) from each symptom. The MSAS-SF consists of four subscales: a Global Distress Index, Physical symptom distress score, psychological symptom distress score, and the Total MSAS score \[[@CR23], [@CR24]\]. The MSAS-SF has been widely used and validated in cancer patients, the Chinese version having been validated in the local cancer population \[[@CR23]\] the subscales demonstrating good internal consistency, with Cronbach's alpha ranging from 0.84 to 0.91. In the present study, the Physical symptom distress subscale was used to assess physical symptom distress.

Patients' socio-demographic data were collected at baseline interview, whereas clinical data were extracted from patients' medical record using a standard protocol.

In the present study, all of the above measures were assessed at baseline, with patient satisfaction again measured at each subsequent follow-up assessment.

Statistical analysis {#Sec4}
--------------------

Standard descriptive analyses assessed sample characteristics. We initially used latent growth curve (LGC) analysis for assessing the change of patient satisfaction over the 12 months' follow-up. LGC analysis estimated the initial level of patient satisfaction and the associated slope, the rate of change in patient satisfaction scores. The analysis showed that level of patient satisfaction did not change significantly over time (data not shown). In this paper, we therefore reported the prediction of patient satisfaction at one-year post-baseline. Several variables, including health system and information needs and physical symptom distress consistently predict subsequent psychosocial distress \[[@CR25], [@CR26]\]. It seems likely that distressed patients would be less satisfied. Consequently, we used hierarchical multiple regression analysis to examine if baseline health system information needs, physical symptom distress, anxiety and depression also predicted patient satisfaction one-year post-baseline. The first block (model 1) entered in the hierarchical model consisted of significant demographic and clinical variables. In the second block (model 2), baseline patient satisfaction was entered. The third block (model 3) consisted of baseline health system information needs, physical symptom distress, anxiety and depression. All analyses reported in this paper were conducted using SPSS Statistics version 21.

Results {#Sec5}
=======

Of 380 eligible women approached for recruitment, 20 were excluded due to linguistic or functional incapacity, and 317/360 (88%) gave informed consent and completed the interview (Fig. [1](#Fig1){ref-type="fig"}). With the exception of age, women refusing or lost to follow-up did not differ by demographic or medical factors, nor in their responses to the study variables at baseline. Women refusing or lost to follow-up were significantly older (mean 55.5 years old vs. 52 years old, t = − 2.28, *p* = 0.025) than those who completed the follow-up assessments. A total of 39 (11%) participants died during the study period. Compared to women who survived, those who died during the study were more likely to have recurrent breast cancer (71% vs. 40.9%, *p* = 0.002), have metastatic disease (71% vs. 50.2%, *p* = 0.03) and greater physical symptom distress scores (mean 1.08 vs. 0.56, t = 2.83, *p* = 0.008). For women who survived (*n* = 278) the duration of the study, 213 (77%) successfully completed the one-year post-baseline assessment. Hereafter, the descriptions of the baseline data and multivariate analysis examining predictors of patient satisfaction are based on data from these 213 women who completed the one-year post-baseline assessment. Table [1](#Tab1){ref-type="table"} summarizes the demographic and clinical characteristics of the study sample.Fig. 1Sampling structure and attrition pattern of the studyTable 1Baseline demographic, clinical, and study variables measured for participants (*n* = 213)CharacteristicsParticipants (%)*Demographics*Age (years) mean ± standard deviation (SD)52.03 ± 9.09Marital status Married/cohabiting144 (67.6) Single/divorced/separated/widowed69 (32.4)Education level No/primary formal education78 (36.6) Secondary (completed high school)/Tertiary (college/university)135 (63.3)Total monthly household income (HK\$)^a^ \< \$10,00074 (34.7) \$10,001--30,00083 (39.0) \> \$30,00141 (19.3) Missing15 (7.0)Occupation Full-time/part-time occupation71 (33.3) Retired22 (10.3) Housewife68 (31.9) Unemployed before/after diagnosis50 (23.5) Missing2 (1.0)*Clinical data*Recurrence of breast cancer Yes77 (36.2) No136 (63.8)Metastasis of breast cancer Yes99 (46.5) No114 (53.5)Time since current diagnosis (days) Mean ± SD (median)19.86 ± 49.14 (8)Type of surgery No surgery68(31.9) Breast conserving therapy22 (10.3) Modified radical mastectomy113 (53.1) Modified radical mastectomy plus reconstruction10 (4.7)Undergoing active treatment at baseline Chemotherapy22 (10.3) Radiation therapy17 (7.9) Hormonal therapy8 (3.7) Targeted therapy10 (4.7)*Study variables*Mean (SD) ChPSQ-9 baseline34.97 (5.29) ChPSQ-9 12-months post-baseline (*n* = 213)35.30 (4.69) SCNS HSI need domain baseline35.43 (11.24) MSAS Physical symptom distress subscale baseline0.51 (0.37) HADS Anxiety3.95 (3.93) HADS Depression3.87 (3.86))*SD* Standard deviation, *HK\$* Hong Kong dollars ^a^1 US\$ = 7.8 HK\$*ChPHQ-9* Chinese Patient Satisfaction Questionnaire*SCNS HSI* Supportive care need scale-- Health system information need*MSAS* Memorial Symptom Assessment Scale*HADS* Hospital Anxiety and Depression Scale

Patient satisfaction, health system information needs, physical symptom and psychological distress {#Sec6}
--------------------------------------------------------------------------------------------------

The mean total PSQ scale score was 34.97 (SD5.29) at baseline and 35.30 (SD4.69) at one-year post-baseline, suggesting the level of patient satisfaction was high and stable (Table [1](#Tab1){ref-type="table"}). Repeated measure analysis showed no significant difference of patient satisfaction between baseline and follow-up assessments (F = 0.47, *p* = 049). The mean baseline SCNS Health system information needs score was 35.43 (SD 11.24), indicating a moderate level of unmet need regarding disease and treatment-related information and continuity of care. In contrast, the mean scores on the MSAS measure of physical symptom distress (mean 0.51, SD 0.37), HADS anxiety (mean 3.95, SD 3.93), and HADS depression (mean 3.87, SD 3.86) suggested low levels of physical symptom and psychological distress at baseline.

Predictors of patient satisfaction {#Sec7}
----------------------------------

Linear regression analyses showed patient satisfaction at 12-months post-baseline was not significantly associated with patients' demographic and clinical characteristics. Therefore, only baseline patient satisfaction (PSQ-9), patient disease and treatment-related health service and information needs (HSI needs), physical symptom distress (MSAS physical symptom distress), and psychological distress (HADS Anxiety and HADS Depression) were included in the subsequent hierarchical multiple regression analysis (Table [2](#Tab2){ref-type="table"}). After adjusting for the effect of baseline PSQ-9, the inclusion of HSI needs increased the variance by an additional 5% (β = − 0.23, *p* \< 0.005, model 2). Baseline MSAS physical symptom distress did not predict 12-months post-baseline PSQ scores (model 3). In the final model, the inclusion of HADS Anxiety (β = 0.23, *p* \< 0.05, model 2) and Depression (β = − 0.28, *p* \< 0.005) accounted only for an additional 3% of variance. Baseline PSQ-9 and HSI significantly predicted 12-month post-baseline PSQ. Adjusting for the effect of baseline PSQ-9, patients indicating higher baseline unmet disease and treatment-related needs and with higher baseline depression (HADS-D) scores reported significantly lower satisfaction at 1-year post-baseline, whereas patients with higher baseline anxiety (HADS-A) scores reported significantly greater 1-year post-baseline satisfaction. Post-hoc power analysis was conducted using G\*Power 3.1. With an effect size of 0.14, a sample size of 213 and significance criteria of 0.05, the statistical power was 0.99, suggesting the sample size was sufficient to detect a difference.Table 2Hierarchical multiple regression models predicting patient satisfaction at one-year post-baseline by predictorsBaselineModel 1Model 2Model 3Model 4β95% CIβ95% CIβ95% CIβ95% CIPSQ scores0.30\*\*0.15, 0.380.21\*\*0.06, 0.310.22\*\*0.07, 0.320.21\*\*0.06, 0.31SCNS Health System & Information need scores−0.23\*\*−0.16, − 0.04−0.25\*\*− 0.17, − 0.05−0.26\*\*− 0.18, − 0.06MSAS physical symptom distress scores0.07−0.55, 1.840.13−0.23, 2,56HADS Anxiety scores0.23\*0.04, 0.50HADS Depression scores−0.28\*\*−0.60, −0.09R^2^0.080.130.140.17R^2^ change0.080.050.010.03*PSQ* Patient Satisfaction Questionnaire, *SCNS* Supportive Care Needs Scale, *MASA* Memorial Symptom Assessment Scale, *HADS* Hospital Anxiety and Depression Scale\**p* \< 0.05; \*\**p* \< 0.005

Because baseline satisfaction scores were such strong predictors of subsequent satisfaction, we performed a post-hoc cross-sectional analysis to identify correlates of baseline PSQ-9 scores. Table [3](#Tab3){ref-type="table"} details factors associated with baseline PSQ-9. Baseline patient satisfaction did not associate with patients' demographic or clinical characteristics in linear regression analyses. Therefore, only HSI needs, MSAS physical symptom distress, HADS Anxiety and HADS Depression were included in the post-hoc regression analysis. Only HSI need (β = − 0.27, *p* \< 0.005) was significantly associated with baseline PSQ-9 scores. Patients with higher baseline unmet disease and treatment-related needs reported poorer patient satisfaction at baseline.Table 3Multiple regression model of patient satisfaction at baselineβ95% CISCNS Health System & Information need scores−0.27\*\*−0.19, − 0.07MSAS physical symptom distress scores−0.05−1.79, 0.92HADS Anxiety scores0.12−0.21, 0.24HADS Depression scores−0.19−0.47, 0.002R^2^0.38*SCNS* Supportive Care Needs Scale, *MASA* Memorial Symptom Assessment Scale, *HADS* Hospital Anxiety and Depression Scale\**p* \< 0.05; \*\**p* \< 0.005

Discussion {#Sec8}
==========

The present study examined factors predicting patient satisfaction during the first year following the diagnosis of advanced breast cancer. Consistent with previous studies on patient satisfaction \[[@CR5]\], our study showed most women diagnosed with advanced breast caner reported high level of satisfaction with their care over the duration of the study. The level of patient satisfaction was quite stable over time.

Overall, the study results provide partial support for the hypotheses. As hypothesized, greater perceived unmet needs for disease and treatment-related information and continuity of care during the initial treatment phase predicted subsequent poorer patient satisfaction. This concurred with previous studies that patient-centered models of care predict higher patient satisfaction \[[@CR5], [@CR7]--[@CR10], [@CR27], [@CR28]\]. Our findings also supported the hypothesis that patients experiencing greater depressive symptoms were likely to be dissatisfied with medical care \[[@CR12]\]. Depressed patients often hold negative views of themselves and the world and therefore may appear generally dissatisfied \[[@CR12]\]. Also, depressed patients may be more dissatisfied as their psychosocial issues are not being addressed during consultation \[[@CR12]\]. There is evidence that oncologists often fail to provide much psychosocial support during consultations \[[@CR9], [@CR29]\].

Contrary to our hypothesis, women with more anxiety symptoms reported greater subsequent patient satisfaction. It may be that anxious patients were more likely to raise their concerns with the oncologists, get answers and therefore feel more satisfied with their medical care. Despite efforts to the contrary, many oncologists seldom actively explore and identify patients' concerns, but will usually appropriately respond to concerns raised by patients \[[@CR9]\]. Physical symptom distress did not predict patient satisfaction. Previous studies showed patient dissatisfaction to be related to inadequate information provision on managing physical symptoms, but not the frequency of physical symptoms \[[@CR11]\]. The results of the post-hoc analysis we performed are consistent with this. Satisfaction at baseline was inversely associated only with HIS needs. These findings reiterate the importance of addressing patients' information and psychosocial needs as much as physical needs. Lastly, our findings indicated that patient demographic factors had little effect on patient satisfaction. There is little consistent evidence that patient demographic characteristics influence patient satisfaction \[[@CR5]\].

This study has several limitations. First, we used a generic measure of patient satisfaction, but one designed for use in the specialist out-patient services that these patients attended. The measure assesses care provided by doctors and also nurses, and emphasizes care-related communications \[[@CR15]\]. It may not capture all the issues in relation to oncology care, such as more technical information. Future studies should consider using a more oncology-specific patient satisfaction measure such as Patient Satisfaction and Quality in Oncological Care questionnaire \[[@CR30]\]. Second, the baseline was assessed only at the start of chemotherapy and therefore was unable to examine prior patient satisfaction at the diagnostic phase.

Conclusions {#Sec9}
===========

We understand the present study to be the first longitudinal study describing patient satisfaction among women diagnosed with advanced breast cancer. The findings highlight most of this sample of Chinese women with advanced breast cancer were satisfied with their medical care. However, high level of unmet health system and information needs predicted longer-term poor patient satisfaction. This highlights the need to reinforce the importance of patient-centered care model in consultations for managing advanced breast cancer.
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